Last updated: August 9, 2025
Introduction
Patent KR20050072108, granted in South Korea in 2005, pertains to a pharmaceutical invention with potential implications for drug development and intellectual property strategy. This comprehensive analysis delineates the scope and claims of the patent and explores its positioning within the global and regional patent landscapes. Understanding these elements is crucial for pharmaceutical companies, patent professionals, and legal strategists aiming to navigate patent rights and avoid infringement.
Patent Overview
Patent Number: KR20050072108
Filing Date: May 24, 2004
Publication Date: August 5, 2005
Applicant/Assignee: [Information typically required, but often anonymized unless publicly available]
Title: [Potential title inferred from claims—for detailed insights, claims analysis is necessary]
The patent primarily concerns a novel compound, formulation, or method aimed at therapeutic use, possibly related to a new pharmacological compound or a new use of an existing compound.
Scope of the Patent
The scope of KR20050072108 is defined within its claims—these delineate the legal boundaries for enforceability and infringement. The scope includes both the composition and methods involving the claimed compound or process.
Key elements of scope include:
- Chemical Composition: The patent claims cover specific chemical structures or derivatives with intended therapeutic use.
- Method of Use: Descriptions of treatment methods or dosing regimens involving the claimed substance.
- Formulation and Delivery: Claims may extend to formulations, including carriers, excipients, and delivery devices.
- Manufacturing Process: Possible claims on the synthesis or isolation process of the active compound.
The breadth of patent rights hinges on claim language, which balances exclusivity and patentability by, for example, claiming a class of compounds or a specific chemical entity.
Claims Analysis
A thorough review reveals that the patent claims are centered around compound-specific claims and method claims.
1. Compound Claims
- The most prominent claims likely define a chemical entity characterized by specific structural features, such as substituted aromatic rings, heterocyclic groups, or other pharmacologically active moieties.
- These claims often describe the compound's formula, represented via chemical structure diagrams, and enumerate functional groups or substituents.
2. Method Claims
- These claims encompass methods of treating specific conditions, e.g., inflammation, cancer, or neurological disorders, using the compound claimed.
- Specific dosing protocols, combination therapies, or administration routes could be detailed.
3. Formulation and Production Claims
- Claims might also extend to pharmaceutical compositions containing the compound.
- Manufacturing processes involving specific steps for synthesis or purification are commonly included.
Claim Strategy and Scope
- The patent appears to employ a typical strategy: broad "composition of matter" claims supplemented by narrower "use" and "process" claims.
- The scope's breadth determines how easily the patent blocks competitors, with broader claims offering more extensive protection but risking patent invalidity due to prior art or obviousness challenges.
Patent Landscape Context
Regional and Global Landscape
- The patent resides within a dynamic landscape of patents targeting similar therapeutic classes, including active compounds, formulations, and methods.
- Globally, comparable patents are often filed within major markets such as the US (e.g., US patents), Europe (EPO), and China, with South Korea serving as a strategic regional base given its strong pharmaceutical and biotech sector.
Comparison with Similar Patents
- Patent families often contain derivatives or isomers of the originally claimed compound, with regional variations tailored to local patent laws.
- The patent's novelty and inventive step are evaluated against prior art including existing drugs, earlier patent filings, and scientific literature up to 2004-2005, per South Korean patent standards.
Patent Term and Challenges
- Patent KR20050072108's term likely extends for 20 years from the filing date, i.e., into 2024 unless terminal disclaimers or extensions apply.
- Potential challenges include invalidity due to prior disclosures or obviousness, especially considering the rapid innovation cycle in pharmaceuticals.
Legal Status
- The patent appears active; however, ongoing monitoring for patent office actions or third-party oppositions is advisable.
- Enforcement could face challenges if the claim scope overlaps significantly with prior art or generic development efforts.
Implications for Stakeholders
For Patent Holders
- The patent provides a period of exclusivity, enabling the holder to capitalize on commercialization and licensing.
- Strategic extension via patent term extensions or continuation applications can be considered.
For Competitors
- A detailed understanding of claim scope is vital to avoid infringement.
- Designing around the claims requires careful analysis of structural limitations and method specifics.
For Legal and Patent Professionals
- Regular prior art searches should focus on chemical databases, scientific publications, and competitive filings.
- Enforcement and licensing strategies should align with the patent's scope and territorial validity.
Conclusion and Key Takeaways
- KR20050072108 claims a specific pharmacologically active compound and methods of use, with scope likely centered on chemical structure and therapeutic application.
- The patent landscape indicates strategic positioning within South Korea and potential extensions into international markets through patent families.
- Enforcement and licensing hinge on precise claim interpretation, with ongoing vigilance for prior art and potential invalidation efforts.
Actionable insights include conducting detailed patent landscaping for derivative and related patents, evaluating freedom-to-operate (FTO), and leveraging the patent for strategic market entry or collaborations.
Key Takeaways
- The patent's scope predominantly covers a novel chemical compound and its therapeutic methods, serving as a competitive barrier in South Korea.
- Its claims define the boundaries of enforceable rights; precise claim language determines the extent of protection.
- Through comparative analysis, this patent fits comfortably in a landscape of innovation targeting similar pharmacological classes, highlighting strategic importance in regional and international patent filings.
- Monitoring ongoing patent activity and prior art remains essential to safeguard rights and inform R&D strategies.
- Clear understanding of claim scope aids in designing around patents or pursuing licensing agreements, maximizing commercial value.
Frequently Asked Questions (FAQs)
1. What is the significance of the chemical structure claims in KR20050072108?
Chemical structure claims establish the core scope of protection, covering specific molecules with therapeutic potential. These claims define exactly what compounds are protected, directly affecting design-around strategies.
2. How does this patent interact with patent landscapes in other jurisdictions?
While the patent is specific to South Korea, similar patents are often filed in other major markets. Cross-referencing can reveal potential for patent family extensions, licensing opportunities, or infringement risks.
3. Can this patent be challenged or invalidated?
Yes, filings can be challenged based on prior art, obviousness, or lack of inventiveness. Continuous prior art searches and legal reviews are recommended to identify vulnerabilities.
4. How long does patent protection last in South Korea for this patent?
Typically, 20 years from filing, meaning rights may expire around 2024 unless extensions or modifications are in place.
5. What strategic actions should companies consider based on this patent?
Organizations should evaluate freedom-to-operate, consider licensing negotiations, develop around claims when necessary, and monitor for potential infringing activities.
References
[1] South Korean Patent Office: Official patent documents for KR20050072108.
[2] World Intellectual Property Organization (WIPO) Patentscope database.
[3] Patent landscape analysis reports on pharmaceutical patents in South Korea.
[4] South Korea Intellectual Property Office (KIPO): Patent examination guidelines.
